Bristol-Myers Squibb Key Facts
The global business at a glance...
|
Chief Executive Officer (CEO):
|
Lamberto Andreotti |
|
Headquarters:
|
New York City |
|
Website address:
|
www.bms.com
|
|
Stock exchange listing:
|
BMY (New York Stock Exchange)
|
|
Number of employees:
|
27,000 |
|
Net sales:
|
$US 21.2 billion (2011) |
|
Research and development:
|
$US 3.8 billion (2011) |
|
Key business:
|
Biopharmaceuticals |
The Australian business at a glance...
|
Australian head office:
|
556 Princes Hwy Noble Park North Victoria 3174 |
|
Number of employees:
|
>150 |
|
Australian sales:
|
$230 million (2010) |
|
Key Products:
|
ABILIFY® (aripiprazole)
AVAPRO® (irbesartan)
AVAPRO HCT® (irbesartan and hydrochlorothiazide)
BARACLUDE® (entecavir)
DUOCOVER® (clopidogrel hydrogen sulphate and aspirin)
ELIQUIS® (apixaban)
ISCOVER® (clopidogrel hydrogen sulfate)
ONGLYZA® (saxagliptin)
ORENCIA® (abatacept)
PERFALGAN® (paracetamol)
REYATAZ® (atazanavir sulfate)
SPRYCEL® (dasatinib)
YERVOY™ (ipilimumab) |